🔗 Visit the ClinicalTrials.gov page for NCT00171314
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Future directions of bone-targeted therapy for metastatic breast cancer. | Nat Rev Clin Oncol | 2010 | 1.27 |
| 2 | Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction. | Br J Cancer | 2010 | 0.91 |
| 3 | Breast Cancer: Rank Ligand Inhibition. | Breast Care (Basel) | 2010 | 0.88 |